Cheek
Implant
Surgery

Learning objective

Classify four fictional midface requests by the concern an aesthetic solid cheek implant could address, the concern it cannot be assumed to address, and the assessment or referral each unresolved concern requires.

In this lesson

• Define the intervention precisely: A solid aesthetic cheek implant is a shaped device considered to add projection or volume to a selected malar or submalar contour. Begin with the appearance change the patient actually seeks, the view in which it matters, and whether an added structural contour plausibly addresses it. The term cheek augmentation is broader: professional guidance also includes autologous fat transfer and injectable fillers. Naming the intervention prevents evidence, expected effects, and complications from one method being silently assigned to another. An implant is a proposal for an individual patient, not the automatic response to a flat-cheek description.
• Separate contour from other clinical questions: A request for a higher-looking cheek can refer to skeletal projection, diffuse soft-tissue hollowing, descent, the lower eyelid, or the relationship between several facial regions. Record the patient's words before translating them into hypotheses. A solid implant may change the contour over which soft tissue lies, but it should not be presented as a guaranteed skin lift or a treatment for eyelid disease. Similarly, maxillary position and occlusion are separate from an isolated cheek-contour goal. Keep each concern visible so an attractive simulation does not hide an untreated functional question.
• Distinguish similar-sounding implants: A cosmetic malar implant is not a dental zygomatic implant. The latter term refers to implants used in selected maxillary prosthetic rehabilitation, with different indications, endpoints, teams, and follow-up. Neither dental implant survival nor chewing outcomes establish the aesthetic performance of a solid cheek implant. Reduction malarplasty also asks a different directional question: it reduces or repositions prominence rather than adding projection. Define which intervention the patient means before discussing research or consent, particularly when the referral note says only 'zygoma implant' or 'cheek surgery'.
• Set professional and educational boundaries: This course develops decision, consent, and follow-up reasoning for primary adult aesthetic augmentation. It does not teach implant placement steps, grant surgical competence, or substitute for a surgeon's examination, device information, and local care pathway. Prior trauma, congenital difference, major asymmetry, suspected orbital or sinus disease, or a complex revision may change the clinical question substantially. Document what can be assessed in an aesthetic consultation, what remains uncertain, and which qualified specialty should own each distinct question before a recommendation is finalized.

Learning objective

Produce a ranked, patient-worded goal record for a fictional case that separates projection, fullness, asymmetry, and overall balance, and identifies at least two outcome limits for discussion.

In this lesson

• Elicit the patient's own target: Ask the patient to point to the exact region and explain which view, expression, or social context makes the concern apparent. 'Fuller cheeks' may mean a forward malar highlight, filling below the prominence, softer hollows, or improved left-right resemblance. Capture the patient's ranking rather than treating those changes as interchangeable. Professional candidacy guidance emphasizes an individualized decision made for the patient, not to conform to someone else's ideal. A precise goal becomes the reference for options, consent, and eventual outcome review.
• Map projection and fullness separately: Projection describes the apparent forward or lateral contour of the cheek prominence; fullness may describe more diffuse volume in the cheek below or around it. A patient can have adequate prominence yet dislike a submalar hollow, or seek sharper bone definition without wanting a globally fuller face. Use frontal, oblique, and profile descriptions to avoid assuming that one adjective identifies a device shape. An observed flat appearance can arise from both structural and soft-tissue contributors; the proposed effect should be worded as a plausible contour change, not a guaranteed measured gain.
• Characterize asymmetry before promising correction: Record which side looks different, in which view, and whether the difference persists at rest and with expression. Separate a patient-prioritized asymmetry from a subtle examiner observation. Facial asymmetry can involve skeletal form, tissue thickness, expression, camera pose, or a combination; photographs alone cannot assign a cause. A device may reduce a specific contour disparity while leaving other sources of difference intact. Frame realistic improvement around the patient's chief concern and the planned domain rather than promising exact bilateral symmetry.
• Discuss facial balance without prescribing an ideal: Cheek shape is perceived in relation to the nose, eyelids, maxilla, jaw, and soft-tissue envelope. Identify the neighboring feature that makes the requested change meaningful, but avoid translating a population ratio or digital preview into a mandatory aesthetic target. Ask what amount of visible change would be sufficient, what degree would feel excessive, and which tradeoffs the patient would reject. Record one possible benefit and one likely unchanged feature. This shared language is more useful for consent than a claim that a standardized 'ideal cheekbone' can be created.

Learning objective

Construct a three-domain differential for two fictional midface presentations and state the additional evidence needed before attributing either appearance to bone, volume loss, or descent.

In this lesson

• Treat surface contour as an observation: A photograph can show a relatively flat or hollow midface, but cannot by itself prove that the zygomaticomaxillary skeleton is underprojected. Begin with the visible pattern in consistent views and the patient's time course: lifelong shape, gradual age-related change, or a change after illness or prior treatment. Ask whether the desired result is focal projection or restoration of broader soft-tissue fullness. Label the skeletal explanation as a hypothesis until clinical examination and, when indicated, other assessment clarify it. This avoids making a permanent device the default answer to every hollow cheek.
• Distinguish focal contour from volume loss: Soft-tissue loss may be diffuse, asymmetric, or concentrated below the malar prominence. Compare the surface pattern with the patient's history, tissue quality, weight stability, and neighboring areas. An implant can add a fixed structural contour, but it is not synonymous with replacing a distributed volume deficit. Fat transfer and fillers address volume in different ways and have their own limitations. Where both skeletal and soft-tissue factors may contribute, state the uncertainty and compare possible combined or staged questions without claiming that one photograph establishes which tissue is responsible.
• Identify descent as a separate mechanism: A complaint about tissue hanging lower, a deepening fold, or a lengthened lid-cheek transition may reflect tissue descent as well as volume change. A cheek implant can alter underlying contour and may affect the apparent fullness, but does not reliably reposition descended tissue or correct lower-eyelid function. Facial lifting procedures address different tissue relationships and must be evaluated on their own indications and risks. Ask which part of the patient's concern is position rather than amount of tissue, and record the feature an isolated implant might leave unchanged.
• Make the differential affect the decision: Classify the working problem as predominantly structural, predominantly soft-tissue volume, predominantly descent, mixed, or unresolved. This is a provisional reasoning aid, not a diagnostic score. For each category, state what evidence would change the pathway and who should obtain it. A patient may reasonably choose observation when a small concern does not justify the burden of any procedure. If the clinical question concerns occlusion, the orbit, or complex reconstruction, do not use the aesthetic implant discussion to close it without qualified review.

Learning objective

Create an option comparison for a fictional patient that links implant, fat transfer, filler, lifting, observation, and referral to their distinct intended effects, uncertainties, and risk conversations.

In this lesson

• Compare options by intended change: Present a solid implant as a structural contour option and autologous fat transfer as a way to add the patient's own tissue to selected soft-tissue regions. Injectable fillers are a nonsurgical device option for temporary or product-dependent volume change; regulatory approval depends on the specific product and use. A lifting procedure targets descended tissues rather than substituting for skeletal projection. Observation can be a valid choice when the concern is limited or the tradeoffs are unacceptable. Use the patient's ranked goal to compare these options, not a universal treatment hierarchy.
• Keep different risk profiles separate: Consent must match the intervention discussed. Implant-specific issues include displacement, contour dissatisfaction, infection, sensory change, and possible revision; fat transfer adds donor-site and fat-survival questions. Filler counseling includes injection and product-specific risks, including vascular complications described by the FDA. The ASPS cheek safety page lists implant and fat-transfer complications together, so its items must be attributed carefully; rare blindness in that list is identified as a fat-transfer complication, not as evidence of blindness from a solid cheek implant. No option is risk-free or automatically reversible.
• Use comparative studies within their limits: Small comparative studies in transfeminine facial augmentation are useful for demonstrating how different options can be evaluated, but they do not establish the superior treatment for all adults seeking cheek contour change. One retrospective cohort had unequal implant and fat-transfer groups and short average follow-up; a prospective pilot studied a small specialized population. Their endpoints and populations should be stated when cited. Patient preference, anatomy, anticipated contour, procedural burden, and uncertainty still govern the individual discussion rather than a headline satisfaction percentage.
• Recognize when referral changes the question: New occlusal symptoms call for dental, orthodontic, or maxillofacial evaluation according to the finding; a cosmetic implant is not bite treatment. Orbital, sinus, or lower-eyelid symptoms likewise require appropriate examination before a cheek procedure is framed as the solution. A patient seeking dental zygomatic implant rehabilitation belongs in a prosthetic and maxillofacial pathway, not an aesthetic-implant comparison. Record the specialist question, the information to share, and whether the aesthetic decision should be deferred. Referral is part of a complete options discussion rather than a failed consultation.

Learning objective

Annotate a fictional midface record with zygomaticomaxillary support, malar prominence, submalar contour, and soft-tissue envelope, then explain three ways their differences alter the augmentation question.

In this lesson

• Describe the bony framework without a device prescription: The zygoma and adjacent maxilla form a structural framework beneath the visible midface. A patient's surface shape reflects that framework through skin, fat, muscle, and their individual distribution; the outer contour is not a direct map of bone. Compare frontal, oblique, and profile findings and identify where projection appears limited or adequate. A statement such as 'underprojected cheekbone' should remain a clinical hypothesis until the examination supports it. The educational task is to understand the relationship between structures and the requested contour, not to select an implant dimension from a generic facial ratio.
• Differentiate malar and submalar goals: The malar region refers to cheekbone prominence and its visible highlight, whereas the submalar region describes the contour below that prominence. A request for a sharper high cheek may differ from a request to fill a lower hollow. The terms help communicate where the patient wants change; they do not, alone, establish a device shape or operative plan. Map the patient's finger-pointed region against photographs and examination, and document whether adding a fixed contour would answer the leading concern or risk adding volume to a region the patient already considers full.
• Account for the soft-tissue envelope: Skin thickness, facial fat distribution, scarring, and tissue mobility can influence how a structural change appears and how palpable or visible a device might become. Record tissue characteristics and prior interventions as assessment findings, without pretending a photograph predicts their response. A thin envelope and a thick envelope may create different questions about contour visibility, yet neither yields an automatic device choice. If the concern is diffuse fat loss or descent, revisit whether a fixed onlay contour is the best match to the patient's aim.
• Use anatomy to organize uncertainty: A useful midface map separates bone position, malar and submalar surface, lower-eyelid transition, oral and sinus history, and the patient's target. Note what is observed, what is inferred, and what requires specialist or imaging review if the finding would alter care. Normal variation is not a pathology label. An anatomical diagram can improve communication among clinicians and the patient, but it cannot guarantee a final contour or replace individualized assessment of asymmetry and adjacent structures.

Learning objective

Identify the infraorbital sensory region and three adjacent anatomical or functional concerns in a fictional case, then formulate individualized baseline and referral questions without stating a universal safe zone or imaging rule.

In this lesson

• Map the infraorbital sensory question: The infraorbital nerve exits through the infraorbital foramen and contributes sensation to the lower eyelid, cheek, nasal sidewall, and upper lip. Ask about prior numbness, tingling, pain, or side-to-side difference and record a relevant examination baseline within the clinician's competence. A CT study of 44 adult hemifaces demonstrates that landmarks can help describe the foramen but cannot define a universally safe coordinate for a particular patient. The lesson uses this anatomy to frame consent and assessment, never as a dissection guide or nerve-clearance measurement.
• Keep orbital and eyelid concerns visible: The cheek lies near the lower orbital rim and the lower eyelid. A patient's complaint about lid position, visual symptoms, previous orbital injury, or eyelid surgery may change the assessment or specialist coordination needed. Record whether the goal concerns the cheek contour or the eye region, and do not imply that added cheek projection will correct eye function. A proposed implant boundary or image must be interpreted in the context of the patient's actual anatomy and clinical findings; a generic diagram cannot establish orbital safety for everyone.
• Ask focused sinus and maxillary questions: The maxilla, maxillary sinus, upper dental structures, and midface contour are neighboring regions with different clinical purposes. Prior sinus disease, maxillary surgery, trauma, or unexplained symptoms may warrant further evaluation before an elective contour decision. The course does not prescribe a routine scan or declare an isolated history item a contraindication. Instead, write the question that imaging or an appropriate specialist would answer and explain how the answer would change the decision. Avoid importing complication rates from dental zygomatic implants, whose prosthetic pathway is different.
• Distinguish dental function from cosmetic contour: Record dental status, prior implants or upper-jaw procedures, and any bite or chewing concern separately from the aesthetic goal. A zygomatic dental implant supports prosthetic rehabilitation in selected maxillary patients; a solid cosmetic cheek implant is considered for external contour. Orthognathic assessment addresses jaw position and occlusion when relevant. If a patient describes altered bite, dental infection, or planned prosthetic work, identify the dental or maxillofacial owner and coordinate before claiming a cheek contour plan will solve the complaint.

Learning objective

Design a fictional predecision baseline that records the patient's contour goal, comparable views, side-specific sensation, and relevant eyelid, sinus, and dental or jaw-function questions without mistaking photographs for a diagnosis.

In this lesson

• Create comparable appearance records: Frontal, oblique, and profile photographs can help describe the cheek region when head position, expression, framing, and lighting are consistent enough for comparison. Obtain and store images according to applicable patient consent and privacy rules. Mark which feature the patient identifies as most important and which differences are merely observed by the examiner. A photograph documents appearance at a moment in time; it cannot establish the cause of an asymmetry, measure hidden skeletal support reliably, or replace a direct examination.
• Record asymmetry across views and expression: An apparent left-right contour difference may vary with camera angle, head rotation, smile, or resting expression. Describe its location and persistence rather than announcing that the bone is asymmetric. Include pre-existing scars, soft-tissue changes, or prior augmentation in the observation record. If the patient cares only about one view, still consider whether a proposed change could be undesirable in another. A baseline that separates patient concern, visible finding, and inferred cause makes later satisfaction and revision conversations more fair.
• Document sensation before attribution: Ask specifically about altered feeling in the lower eyelid, cheek, nasal sidewall, and upper lip, including prior dental or facial procedures. Record laterality, duration, and any relevant clinician-observed difference before surgery is contemplated. Without a baseline, a pre-existing sensory symptom may later be incorrectly attributed to an implant, or a new change may be missed. The assessment does not turn this course into a neurologic diagnostic protocol; unexplained or progressive findings require appropriate clinical review.
• Keep function distinct from appearance: The cheek contour goal should sit alongside separate questions about lower-eyelid position and symptoms, vision when relevant, sinus symptoms, occlusion, chewing, and planned dental care. A pleasing photograph is no evidence of normal function. State which findings are within the treating clinician's assessment and which warrant another specialist. Record the proposed outcome domain in advance: external contour may be assessed against photographs and patient goals, whereas dental and orbital complaints require their own clinical pathways.

Learning objective

Prepare a fictional candidacy and consent memo that identifies health and treatment-history questions, tests expectations against the proposed contour effect, compares alternatives, and names at least four implant-relevant risks or uncertainties.

In this lesson

• Review health as an individualized risk question: The consultation should elicit medical conditions, allergies, treatments, medications and supplements, tobacco and other substance use, and relevant health risks. Professional candidate guidance discusses general health, stable weight, smoking, and realistic expectations, but does not supply a validated clearance score or make every thin or sagging cheek an implant indication. The treating team determines what optimization, anesthesia review, or further assessment is needed for the actual patient. Record unanswered questions and decision ownership rather than declaring someone cleared from a checklist.
• Interpret prior procedures and local history: Ask about prior cheek, eyelid, orbital, sinus, dental, maxillary, and facial procedures, including implants, fillers, fat transfer, trauma repair, and infection. The history can alter anatomy, scar quality, expectations, and the meaning of a new symptom. Confirm what was done rather than assuming a patient's use of 'implant' identifies a solid cosmetic cheek device. If prior records or device details would materially change a recommendation, obtain them through the treating pathway. Complex revision or reconstruction is outside this primary aesthetic course's routine decision scope.
• Test expectations and acceptable tradeoffs: Ask what result would satisfy the patient, which differences they can accept, and what they believe the implant will change. A request for exact symmetry, a photographic clone, a guaranteed lift, or an assurance that removal restores the original face needs clarification before consent. Discuss visible or palpable contour, altered sensation, swelling, persistent dissatisfaction, and the possibility of later care in patient-specific terms. The choice to defer or decline remains legitimate when likely benefits do not justify uncertainty for that person.
• Make consent a comparison, not a signature: A defensible consent discussion names the proposed implant goal, plausible limitations, alternatives including observation, material risks, and who to contact about postoperative concerns. Implant-relevant risks in professional guidance include asymmetry, bleeding, infection, displacement, sensory change, poor wound healing, pain, tissue response, and revision. Avoid assigning fat-transfer donor-site or filler vascular risks to the solid device. Ensure the patient can explain the intended change and major tradeoffs in their own words; the signed form records rather than replaces that conversation.

Learning objective

Classify a fictional patient's requested change as principally malar, submalar, combined, or outside the scope of an implant, and defend the classification using documented baseline findings.

In this lesson

• Translate the requested change into a contour region: Malar augmentation emphasizes the prominence of the cheekbone region, whereas submalar fullness concerns the area beneath that prominence. Ask the patient to identify the exact appearance they hope to change in their own words and photographs, then record whether the desired effect is projection, fullness, or a transition between regions. A broad wish for a younger face is insufficiently specific to select an implant. The consultation should also note concerns that originate in the lower eyelid, skin envelope, or lower face rather than the proposed implant region.
• Relate contour goals to the baseline examination: Compare frontal, oblique, and profile impressions with palpated skeletal form, visible soft-tissue volume, and any asymmetry. A flat-appearing cheek does not by itself establish skeletal underprojection: light, photography, soft-tissue loss, and descent may change the apparent contour. Record where the patient sees the deficit and where the clinician finds a plausible structural target. If those locations disagree, explain the mismatch before discussing a device. This keeps the plan anchored to an observed problem rather than to a catalog shape or a generic aesthetic ideal.
• Test whether a combined goal remains coherent: Some patients want both a higher malar highlight and lower cheek fullness. A combined goal can be discussed, but each component should have a separate rationale and a stated limit. Adding projection in one region may change the perceived balance of another without correcting actual soft-tissue descent. The discussion should include how the two sides differ at baseline and whether aiming for perfect symmetry is realistic. The final decision remains individual; the terms malar, submalar, and combined describe goals, not automatic indications or standardized device dimensions.
• Recognize when another option answers the question better: If the principal concern is diffuse soft-tissue depletion, fat transfer or a suitable injectable filler may warrant a separate discussion; if it is tissue descent, a lifting evaluation may be more relevant. Observation is also a valid choice. These approaches have different mechanisms and risks, so a response to filler does not prove that a solid implant will reproduce the same appearance. Record the patient’s preference for a device, their tolerance of uncertainty, and the reason for declining or referring away from implant planning when the target is unclear.

Learning objective

Construct a balanced comparison of standard and patient-specific solid implant concepts, identifying at least three selection questions and two evidence limits without ranking a material as universally superior.

In this lesson

• Define the device question before naming a material: A solid cheek implant is a medical device intended to alter facial structure or contour. The patient’s intended region, baseline asymmetry, tissue coverage, previous facial procedures, and willingness to accept an implanted device should frame any later design discussion. Document what contour problem the device would address and what it would leave unchanged. Material choice is a separate clinical and device-specific decision made by the treating surgeon with the patient; the educational comparison cannot substitute for the product’s instructions, availability, or local regulatory status.
• Read the available material evidence without false ranking: Published series describe silicone elastomer malar implants and porous-polyethylene or PEEK malar onlays, but their patients, designs, indications, and follow-up differ. The silicone series included many concurrent facial procedures; the onlay series was a single-surgeon observational cohort. Neither supplies a fair head-to-head material comparison or a patient-specific complication estimate. Use them to formulate questions about tissue response, stability, imaging visibility, revision, and follow-up, while separating what the study actually measured from what a proposed device is claimed to achieve.
• Compare standard and patient-specific design concepts: A standard implant offers established shape families and may be considered when the anatomical and contour question is straightforward. A patient-specific design may be discussed when substantial asymmetry or unusual skeletal form makes an off-the-shelf shape a poor conceptual fit. Customization adds design, review, manufacturing, and documentation questions; it does not guarantee a superior appearance or remove operative risk. The treating team must check the exact device characteristics and suitability for the individual. Do not infer that a digitally tailored shape predicts the soft-tissue result precisely.
• Anticipate the consequences of a long-lived device: An implanted device can create later questions about displacement, visibility, palpable edges, infection, tissue response, or dissatisfaction. Revision or removal can require another operation and may not simply restore the preimplant contour. During consent, compare these possibilities with the patient’s expectations about durability and reversibility. A claim that one material always integrates better, is easier to remove, or is safer would require device- and population-specific comparative evidence that the cited series do not provide. Keep uncertainty visible in the shared decision record.

Learning objective

Critique a proposed visual simulation against a fictional patient's anatomy and identify four disclosures needed to prevent an appearance guarantee.

In this lesson

• Connect the contour proposal to specific baseline evidence: A contour concept should be described in relation to the patient's documented views, asymmetry, skeletal form, soft-tissue thickness, and stated priorities. Distinguish a structural projection target from volume loss or descent that a solid implant may not resolve. Record what would count as a meaningful improvement for the patient, including which imperfection they would accept. Comparing that target with baseline findings is more informative than matching a computer image or a celebrity reference. If the proposed contour requires changes outside the cheek region, revise the question before proceeding.
• Explain what visual planning can and cannot predict: Photographs and digital renderings can support a conversation about direction and proportion, but they are representations rather than a promise of final tissue behavior. Lighting, head position, expression, swelling, healing, and existing asymmetry alter apparent contour. Even a patient-specific device shape does not determine how overlying tissues will look at every angle. Label images as discussion aids, record the assumptions behind them, and ask the patient to restate the uncertainty. Avoid using a single rendering as the consent endpoint or as evidence of an exact attainable result.
• Evaluate transitions and adjacent features: The proposed cheek shape should be considered with the lower eyelid, lateral midface, nasolabial region, and opposite cheek so that a local increase in projection does not create an unwanted transition. This is a qualitative planning task, not a prescribed implant size or operative placement. Identify any orbital, dental, sinus, or sensory question that could alter the plan and assign it to the appropriate clinician for assessment. A shape that appears balanced in one view may be conspicuous from another, especially in an already asymmetric face.
• Convert uncertainty into a consent conversation: Agree on a range of plausible appearance outcomes rather than a pixel-perfect image. Discuss residual asymmetry, under- or overcorrection, implant visibility or palpability, and the possibility of later revision, while avoiding a numerical probability unsupported by the patient's context. Confirm the patient's own threshold for an acceptable result and document any expectation that no reasonable implant plan can meet. When disagreement persists between goals and likely effects, defer the elective decision and revisit options or obtain another opinion rather than treating the rendering as a commitment.

Learning objective

Decide whether a fictional patient's unresolved anatomical questions justify imaging or specialist input, and produce a coordinated plan that distinguishes cheek augmentation from any adjunct procedure.

In this lesson

• Ask what additional information would change the plan: Clinical examination and standardized photographs form the starting record. Imaging is a conditional tool when a specific anatomical or prior-surgery question cannot be resolved adequately from the clinical assessment and would change a decision. Examples include marked skeletal asymmetry or uncertainty about adjacent structures, but no study in this course establishes routine imaging for every cheek-implant candidate. State the decision question, expected benefit, limitations, and who will interpret the study. Incidental or conflicting findings may require a separate assessment before elective device planning continues.
• Keep infraorbital, orbital, sinus, and dental questions explicit: The infraorbital foramen and nerve vary between individuals. An anatomical CT study illustrates this variability but cannot provide a universal safe coordinate for an individual patient. A history of altered facial sensation, orbital symptoms, dental disease, sinus problems, or prior midface surgery changes the consultation and may call for specialist review. Record which concern has been identified and who owns follow-up. Do not convert study averages into operative clearance distances or assume that a facial aesthetic assessment resolves dental or orbital pathology.
• Separate the effects and risks of proposed adjuncts: A patient may ask about combining an implant with lifting, lower-eyelid surgery, fat transfer, or a different facial procedure. Each proposal must address its own indication, benefit, risk, anesthesia burden, and recovery plan. Implant-related displacement and device infection differ from fat-transfer-specific problems and from vascular risks of injectable filler. The presence of a combined plan also makes attribution of later results harder, a limitation visible in older malar-implant cohorts. Consent should name the contribution expected from each intervention and permit a staged or no-procedure option.
• Assign decisions to the relevant clinicians: The surgeon retains responsibility for whether a cheek implant is indicated and for discussing achievable contour. The anesthesia professional evaluates anesthesia-related concerns; dental, ophthalmic, otolaryngologic, or other specialists address problems within their scope when findings warrant it. Team communication should identify unresolved questions, who will obtain and interpret information, and what must be settled before scheduling. A referral is a meaningful clinical outcome rather than a failed consultation. Keep the patient informed if a second opinion changes the cosmetic plan or its timing.

Learning objective

Build an individualized preoperative question list for a fictional candidate and assign anesthesia, surgical, and specialist decisions to the correct owners.

In this lesson

• Treat anesthesia assessment as an independent decision: The surgeon’s decision that cheek augmentation may meet an aesthetic goal does not establish fitness for anesthesia. The anesthesia professional reviews the available record, interviews and examines the patient, assesses relevant medical conditions and previous anesthetic experiences, and determines the appropriate care plan. The patient should understand anesthesia options and their individualized risks through that team. Do not infer a preferred method from the course or from a photograph. An elective plan can be deferred if essential information or medical optimization is missing.
• Inventory health and treatment factors that may alter risk: The consultation should elicit current illness, chronic conditions, medications and supplements, allergies, tobacco and substance use, prior surgery, and prior anesthesia problems. Dental or sinus symptoms and active infection deserve attention because the proposed intervention concerns the midface. These prompts are not a universal clearance checklist or a direction to stop a medication. The responsible clinicians decide which findings need examination, testing, treatment, or consultation. Document both the identified risk and the owner of the next action before committing to an elective schedule.
• Assess procedure context rather than copying a routine order set: An implant alone and a combination of operations differ in scope, likely recovery demands, and perioperative planning. Consider whether concurrent procedures or relevant comorbidities change the facility, anesthesia, or follow-up discussion. Testing and consultations should answer patient-specific questions instead of being presented as required for every candidate. The surgeon and anesthesia professional must communicate about intended procedures, known conditions, and anticipated concerns. A change in scope should trigger renewed risk discussion and consent rather than automatic reuse of an earlier assessment.
• Document a decision with uncertainty and handoff: A useful preoperative record distinguishes completed evaluation from unresolved issues and states whether the current status supports proceeding, modification, deferral, or referral. It identifies which clinician will review missing information and how the patient will receive updated recommendations. The patient’s personal threshold for an elective benefit should be weighed against anesthesia and surgical uncertainty; eligibility is not a promise of safety. If the patient elects observation after counseling, that is an acceptable informed decision. Avoid assigning an individual risk percentage without a validated basis.

Learning objective

Classify four fictional postoperative concerns by likely risk domain, required assessment, and escalation owner without prescribing treatment.

In this lesson

• Map infection and wound problems to a device decision: A solid implant creates a device-related context for infection and poor wound healing. The consultation should review relevant current symptoms and health factors, while the treating team explains site care and whom to contact if concerning changes occur. Redness, drainage, wound opening, or systemic illness may require prompt clinical assessment; the educational case should not attempt remote diagnosis or prescribe antibiotics. Because device involvement can alter management and sometimes lead to another procedure, the patient needs clear escalation instructions and an identified surgical contact before discharge.
• Separate expected postoperative change from possible bleeding: Swelling and bruising can occur after facial surgery, yet rapidly increasing asymmetry, tense swelling, new severe pain, or active bleeding should not be dismissed as routine recovery. The relevant clinician needs the timing, location, progression, associated symptoms, and procedure history to judge urgency. Hematoma is listed among cheek-augmentation risks, but population-wide and patient-specific rates are not established by the course sources. Document the emergency route provided by the treating team rather than offering a fixed home-care maneuver or a generic observation period.
• Anchor sensory monitoring to a documented baseline: The infraorbital nerve and surrounding sensory territory make preoperative facial sensation important to record. Ask whether altered feeling, pain, or asymmetry existed before the implant decision, particularly after previous surgery or trauma. Later numbness, tingling, or persistent pain should be compared with that baseline and assessed by the treating clinician, who decides whether further evaluation is needed. A small anatomical study shows variation around the foramen, not a universal nerve-safe zone. Avoid promising that sensory changes will resolve on a particular date.
• Attribute risks to the intervention actually proposed: The ASPS cheek-augmentation risk page groups implant and fat-transfer events together. Implant displacement, device infection, and tissue response belong in an implant discussion; fatty cysts, fat necrosis, and a rare vascular blindness warning from fat transfer must not be relabeled as solid-implant risks. Injectable filler has its own product and vascular-injection hazards. If procedures are combined, assign each harm to its plausible source while acknowledging that the clinician may need to evaluate overlapping symptoms. This precision improves consent and prevents either minimizing or inflating risk.

Learning objective

Analyze a fictional complaint of uneven cheek contour and distinguish possible position, tissue, baseline-asymmetry, and expectation explanations before recommending reassessment.

In this lesson

• Describe implant-specific contour problems precisely: A patient may notice asymmetry, a displaced-looking contour, palpable or visible edges, or a transition that differs from the agreed goal. These observations do not identify a cause by themselves. Compare standardized preoperative and current views, the patient’s own stated target, and the examination, while accounting for healing stage. Do not call every asymmetry a device movement or imply that a photograph proves malposition. The surgeon decides whether clinical evaluation, additional records, or imaging would change management. The patient’s description of impact remains part of the outcome.
• Consider tissue response and persistent symptoms: Scarring around an implant, prolonged swelling, wound concerns, altered sensation, or persistent pain can change appearance and patient experience. The ASPS safety guidance includes thick scar tissue around an implant among possible harms, but the course cannot determine its frequency or mechanism in a particular person. Assess these complaints separately from dissatisfaction with size or shape. A reassuring cosmetic image does not rule out pain or sensory change. Document new symptoms, timing, and clinical findings, then direct evaluation to the treating surgeon and relevant specialists when indicated.
• Avoid premature judgments during healing: Early appearance can be distorted by swelling and healing, so a single early view should not be treated as the final contour. At the same time, a changing wound, marked asymmetry, or significant symptoms should not be postponed solely because recovery is ongoing. Use the treating team's follow-up schedule and escalation guidance to separate routine reassessment from timely review. Any promise that the implant will look exact after a fixed interval exceeds the evidence. The patient should know what remains uncertain and when the next clinical comparison is planned.
• Frame revision and removal as new decisions: Revision may address a defined device or contour problem, but it creates another intervention with its own risk and uncertain result. A selected secondary-surgery series describes patients with displeasing contours and tissue changes; it does not estimate how often a primary recipient will need revision. Removal is not a guaranteed return to the starting appearance. Revisit the original goals, current examination, symptoms, and alternatives before any new proposal. Some patients may prefer observation or a second opinion once a serious complication has been excluded.

Learning objective

Apply a four-way decision framework to two fictional consultations and justify each disposition with goals, evidence, safety, ownership, and consent limits.

In this lesson

• Define what proceeding would require: Proceed is a reasoned elective choice, not a default response to a request for cheek volume. The goal and target region should be clear; the examination, health assessment, and expected device effect should be sufficiently aligned; material uncertainties and alternatives should be understood; and the required clinicians should agree that unresolved concerns have been addressed. Consent should include implant-specific harms and realistic outcome limits. Even when those conditions are met, the patient may choose observation. Record the rationale in language that another clinician could audit without inferring a guarantee of benefit.
• Use modification to correct a mismatch: Modify when the original request contains a workable goal but the proposed device or combined plan does not fit the findings. Examples include narrowing a broad rejuvenation request to a defined cheek projection goal, separating an eyelid concern, or staging another procedure for its own assessment. A modified plan needs renewed explanation of what is being changed and what remains untreated. It should not hide an unresolved safety issue under a new name. Document whether the patient accepts the revised aim rather than assuming an altered plan preserves earlier consent.
• Defer when information or readiness is insufficient: Defer an elective implant decision when an active symptom, uncertain baseline, incomplete medical or anesthesia evaluation, conflicting photographs and goals, or unrealistic outcome expectation could materially change the conclusion. Specify which question must be answered, who will answer it, and what decision can be revisited afterward. Deferral is distinct from a permanent contraindication; it is a transparent limit on current knowledge. Do not promise that a test result or passage of time will eventually make surgery appropriate. The patient remains free to decline the intervention.
• Refer when the main problem lies outside implant scope: A dental, sinus, orbital, neurologic, orthognathic, or complex reconstructive concern may need another specialist before an aesthetic implant decision. Refer when that problem is primary or requires expertise the treating team cannot provide. Explain the purpose of referral and whether cosmetic planning is paused pending findings. Do not assume that a different specialty will recommend surgery or that a cheek implant can correct an occlusal or orbital problem. A clear handoff includes the patient's symptoms, relevant baseline, prior procedures, and the specific question for the receiving clinician.

Learning objective

Construct a patient-specific postoperative handover that identifies care instructions, follow-up ownership, escalation contacts, and questions requiring the treating team's decision.

In this lesson

• A handover anchored to the actual operation: Recovery advice begins with what was actually done: the implant site and design, the incision location, any concurrent procedure, anesthesia course, and findings that alter follow-up. The treating team documents which person owns each instruction and how the patient can reach that team. Generic cheek-augmentation guidance describes possible dressings and intraoral care, but these are conditional examples. A course cannot determine this patient's wound care, medicines, diet, or activity limits from the procedure name alone.
• Written instructions and teach-back: A useful handover gives the patient written, accessible answers about site care, prescribed medication, hygiene, eating if relevant, activity, and the next review. The learner should distinguish an instruction from a question to take back to the surgeon; do not convert examples from a public guidance page into a universal regimen. Ask the fictional patient to explain whom they will contact for an unexpected change, then correct any misunderstanding. If a combined procedure changes the plan, both teams' advice needs reconciliation.
• Follow-up as a safety system: Set review points according to the treating surgeon's plan and the patient's risk and logistics, without imposing a fixed calendar. Record a usable contact route for routine questions, an urgent route for concerning changes, and who follows up a missed appointment. The baseline record of cheek contour, sensation, incision state, and patient-defined goals should be retrievable at review. A symptom report is not a substitute for examination, and a quiet interval does not remove the need for planned reassessment.
• Explaining an uncertain appearance trajectory: Early postoperative swelling can obscure the contour, and healing varies across people and procedures. The discussion should separate temporary uncertainty from a promise that all asymmetry, sensory changes, or dissatisfaction will disappear. The patient receives a clear way to report a change before the next scheduled review. Return to work, exercise, social activity, and any special diet must be individualized by the treating team; neither a photograph nor a course-wide recovery date can certify readiness.

Learning objective

Classify fictional postoperative reports by concern and urgency, document the information needed for assessment, and assign a safe escalation route without prescribing a treatment algorithm.

In this lesson

• Wound and systemic signals: Review what the patient reports about incision separation, drainage, bleeding, swelling, discomfort, and general illness, then compare it with the treating team's written expectations. A worsening or one-sided pattern deserves direct clinical assessment rather than a remote claim that it is normal healing. Infection, hematoma, poor incision healing, and persistent pain are recognized cheek-augmentation concerns, but appearance alone cannot distinguish them. Record onset, progression, associated symptoms, and contact attempts; an authorized clinician decides the examination and treatment.
• Sensory change in context: Compare a new numb or altered-sensation report with the documented preoperative sensory baseline and the immediate postoperative record. Ask about location, laterality, onset, progression, and associated pain or functional symptoms; an unrecorded baseline weakens interpretation. The infraorbital region is anatomically relevant, but a course cannot diagnose nerve injury from a message or prescribe a recovery timeline. Progressive, persistent, or unexpected change should be escalated to the treating surgeon for individualized examination and follow-up.
• Implant position and tissue concerns: A report of new contour asymmetry, a palpable or visible edge, apparent shift, wound opening, or a persistent focal problem raises an implant-specific question. The learner must avoid assuming that early swelling proves malposition, while also avoiding reassurance that every change is merely swelling. Record photographs only through approved clinical channels and arrange the responsible team's assessment. Patients should not be instructed to manipulate the implant; decisions about imaging, observation, revision, or removal belong to the examining specialist.
• Escalation and closed-loop communication: A triage plan names the owner, time-sensitive communication route, and confirmation that the concern was received. New chest pain, shortness of breath, or unusual heartbeats warrant immediate medical attention under ASPS results guidance; local emergency pathways and the individual clinical context govern action. Other concerning reports require prompt contact with the surgical team, with urgency determined by symptoms and examination. Document advice given, patient understanding, and whether the team reached a disposition; do not supply a fixed antibiotic or operative response.

Learning objective

Build an outcome review that compares patient-defined goals and clinical findings with a documented baseline, and identify which conclusions remain uncertain.

In this lesson

• The baseline-goal matrix: Return to the patient's own description of the desired change: projection, fullness, symmetry, or balance in specific views. Pair each goal with baseline photographs, physical findings, and the limits discussed during consent. At follow-up, record the patient's account and the clinician's observed contour separately; neither should be substituted for the other. Standardize photographic views and conditions as much as practical, because lighting, angle, expression, and timing can falsely suggest gain or loss of projection.
• Contour and symmetry across healing: Examine the malar and submalar contour, transition to neighboring regions, implant visibility or palpability, and left-right differences. Compare with baseline asymmetry rather than treating perfect symmetry as the default result. Early swelling can mask or exaggerate a contour judgment, so note the stage of recovery before deciding that a result is stable. A complaint about lower-eyelid position, skin descent, dental occlusion, or diffuse volume loss may signal a separate problem that an implant was never designed to resolve.
• Sensory and tissue outcomes alongside appearance: A pleasing photograph does not close the outcome assessment. Recheck the patient's reported sensation against the preoperative map, ask about persistent or new pain, and examine the incisions and overlying tissues within the clinician's role. Record functional or dental concerns when raised and direct them to the appropriate specialist. Distinguish a previously documented difference from a postoperative change; when uncertainty remains, state it and plan reassessment rather than attaching a definitive cause to a single visit.
• Patient-reported measures and their limits: A structured patient-reported outcome measure can capture satisfaction or symptoms missed by a surgeon's photograph. If a FACE-Q cheeks scale is used, follow its authorized wording, scoring, and intended context, and compare like measurements over time. The cited scale was evaluated in a face-lift sample, not validated here as an implant-specific success threshold. Neither a score alone nor an unstructured statement of satisfaction replaces examination, the original goal, and a record of adverse effects.

Learning objective

Appraise a proposed revision or removal against the patient's specific problem, explain why removal is not a guaranteed reversal, and identify limits of published outcome evidence.

In this lesson

• Define the reason for secondary assessment: Separate dissatisfaction with size or position from infection, wound problems, sensory change, pain, or tissue change. Confirm the primary implant history, material and design if known, prior photographs, co-procedures, and the patient's revised goal. A secondary consultation may need input from the original surgeon or another specialist when anatomy, dental or orbital concerns are involved. The purpose is to frame options and uncertainty, not to promise that an alternative implant or a second operation will solve every complaint.
• Why removal is not a reset button: Secondary malar-implant literature describes selected patients with contour distortion, asymmetry, and infraorbital nerve symptoms. The published series reports that removal may reveal underlying bone or soft-tissue changes, so the preimplant appearance cannot be promised after explantation. Its particular combination of removal, replacement, and tissue resuspension reflects one author's revision cohort and must not become a course-wide treatment recipe. Explain options only after individualized examination, records review, consent, and specialist judgment.
• Reading small outcome series correctly: The available silicone and malar-onlay reports involve small observational cohorts with different devices, indications, co-procedures, follow-up, and outcome definitions. Check whether a paper counts people or implants, whether the treatment was primary or secondary, and how lost follow-up or subjective grading could alter conclusions. A proportion from one surgeon's series is not a patient-specific complication probability or proof of material superiority. Record what each study can support and what it cannot before using it in consent.
• Shared decisions amid evidence gaps: Compare continued observation, further assessment, revision, removal, and treatment of a separate soft-tissue concern by the specific problem they might address. Studies comparing implants with fat transfer in specialized populations do not establish a universal best choice for primary aesthetic patients. Revisit the patient's priorities, burdens of another procedure, possible persistent symptoms, and the uncertainty of long-term contour. Document a reasoned decision and follow-up owner, while avoiding a guarantee of exact symmetry, permanent satisfaction, or simple reversibility.